Jin Medical's New Facility Initiation in Chuzhou
On January 22, 2026, Jin Medical International Ltd. (NASDAQ: ZJYL) announced considerable progress on its manufacturing facility located in Chuzhou, Anhui Province, China. This facility will be operated by Zhongjin Medical Equipment (Anhui) Co., Ltd., a wholly-owned subsidiary of Jin Medical, and it is projected to begin full production by the end of April 2026.
The Chuzhou facility plays a vital role in Jin Medical’s strategic expansion, considering the increasing global demand for rehabilitation medical equipment, especially with the ongoing trend of aging populations worldwide. The Company has completed necessary regulatory filings and has received the license for the production of Class I Medical Devices. This paves the way for the anticipated annual production of 200,000 units of mid-to-high-end electric wheelchairs and senior mobility scooters.
This new facility is strategically located in the heart of the manufacturing hub of the Yangtze River Delta, providing Jin Medical with significant competitive advantages in terms of geography and supply chain efficiency. The location is expected to enhance the Company’s manufacturing prowess in the realm of premium mobility products significantly.
Dr. Erqi Wang, Chairman and CEO of Jin Medical, emphasized the project's importance, stating, “The completion of this project will support our strategic goal of optimizing global production capacities. Our Chuzhou base will reinforce the sustainability of our supply chain and enable us to respond more effectively to market demands, both domestically and internationally.”
In its initial phase of operation, the facility will focus on producing mid-to-high-end electric wheelchairs and senior mobility scooters using advanced automated production lines. This modern methodology aims to optimize cost control while ensuring product quality remains consistently high.
Industry analysts have noted that Jin Medical's expansion efforts are aptly timed with the burgeoning global needs associated with assistive devices, particularly in light of the global aging trend which further demands innovative solutions within this sector. The operations at Chuzhou are expected to amplify Jin Medical’s market competitiveness through scalable and efficient production capacities.
Jin Medical has a track record of delivering innovative and ergonomic wheelchair products and currently operates two existing manufacturing plants that span approximately 230,000 square feet in Changzhou and Taizhou cities, Jiangsu Province, China. The anticipated addition of the new facility, which measures 430,000 square feet in Chuzhou, is an essential component of Jin Medical's growth strategy.
The Company has announced its commitment to executing the project in alignment with its strategic plan, reaffirming its intent to create sustained value for shareholders through operational excellence and effective market execution. As of now, Jin Medical collaborates with over 40 distributors in China and around 20 international distributors, primarily supplying their wheelchair products to these markets, including over 30 distinct wheelchair models available to distributors in Japan and China.
In conclusion, with the Chuzhou facility coming into operation, Jin Medical stands poised to not only enhance its production capabilities but also solidify its market position as a leading provider of mobility solutions globally.
About Jin Medical International Ltd.
Founded in 2006, Jin Medical is dedicated to designing, developing, manufacturing, and marketing wheelchairs and living aids for individuals with disabilities and the elderly, serving important rehabilitation needs. For more information, visit
Jin Medical's official website.